Journal of Pharmacy & Pharmaceutical Sciences
Frontiers Media S.A.
About the journal
Journal of Pharmacy & Pharmaceutical Sciences is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,200 USD. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Frontiers Media S.A.
- ISSN
- 1482-1826
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,200 USD
- Articles in DOAJ
- 805
- Declared review time
- 15 weeks
- Declared peer-review model
- peer_review
Index listings
- DOAJ · 2016-11-03
- MEDLINE · 1998-01-01
- PUBMED · 2004-01-23
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 2,200 USD
- Declared review time (DOAJ)
- 15 weeks
- Actual review time (measured)
- 94 days received→accepted — computed from PubMed (n=52)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
805
Most recent article
last month
Average review time (journal-declared via DOAJ)
15weeks
Works in OpenAlex
826
Last recorded publication year
2026
h-index
68
i10-index
511
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-12
- Added to DOAJ
- 2016-11-03
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPKP PN
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- JPPSJournal of pharmacy and pharmaceutical sciences
- Source type
- journal
- NLM unique ID (PubMed)
- 9807281
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Drug Solubulity and Delivery Systems
- Drug Solubulity and Delivery Systems
- Pharmacogenetics and Drug Metabolism
- Advanced Drug Delivery Systems
- Pharmacogenetics and Drug Metabolism
- Advanced Drug Delivery Systems
Show all subjects (50)
- Advancements in Transdermal Drug Delivery
- Advancements in Transdermal Drug Delivery
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Statistical Methods in Clinical Trials
- Statistical Methods in Clinical Trials
- Pharmaceutical Economics and Policy
- Biosimilars and Bioanalytical Methods
- Pharmaceutical Economics and Policy
- Biosimilars and Bioanalytical Methods
- RNA Interference and Gene Delivery
- Nanoparticle-Based Drug Delivery
- RNA Interference and Gene Delivery
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Practices and Patient Outcomes
- Analytical Methods in Pharmaceuticals
- Analytical Methods in Pharmaceuticals
- Pharmacovigilance and Adverse Drug Reactions
- Pharmaceutical Practices and Patient Outcomes
- Pharmacovigilance and Adverse Drug Reactions
- Inflammatory mediators and NSAID effects
- Inflammatory mediators and NSAID effects
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Drug-Induced Hepatotoxicity and Protection
- COVID-19 Clinical Research Studies
- Inhalation and Respiratory Drug Delivery
- Inhalation and Respiratory Drug Delivery
- Drug-Induced Hepatotoxicity and Protection
- COVID-19 Clinical Research Studies
- Antibiotics Pharmacokinetics and Efficacy
- Dermatology and Skin Diseases
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Dermatology and Skin Diseases
- Antibiotics Pharmacokinetics and Efficacy
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
Keywords (DOAJ)
- pharmacology
- pharmaceutics
- clinical pharmacology
- pharmacy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ